One thing looking at these other start ups, is how good has IHL...

One thing looking at these other start ups, is how good has IHL been from early conception. The very directed goal of our trials. The focus on 1 main treatment while progressing very similar in importance further trials for unmet needs. No wishy washy goals. Everything is very targeted and so far ahead of other small caps in this arena.
So therefore, you wouldn't buy Apirx on a whim....there is a single targeted point to this. The BOD doesn't work any other way. Let's hear it I say.